The authors suggested that c-Myc is overexpressed in the case of pancreatic NETs, which is also associated with the VEGF pathway and increased expression and secretion of vascular endothelial growth factor C (VEGF-C) [49]. The gene discussed is MYC; the disease is pancreatic neuroendocrine tumor.